Stenting as a bridge to surgery for extra-colonic malignancy induced colorectal obstruction: preliminary experience

Table 1 Clinical characteristics of patients

Case No	Sex	Age (range)^a	Cancer origin	Obstruction site	PC	Multi-site obstruction	Previous treatment before colonic obstruction	Neoadjuvant systemic chemotherapy	FUD (d)	Expire
1	F	50–55	Cervical cancer	Upper rectum	No	No		No	109	Yes
2	F	90–95	Pancreas cancer	Splenic flexure	No	No		No	186	Yes
3	M	60–65	AGC	Transverse	Yes	No	Palliative radical total gastrectomy with chemotherapy	No	85	No
4	F	40–45	MUO	Sigmoid	No	No		No	60	No
5	M	55–60	Pancreas cancer	Sigmoid	Yes	No	Distal pancreatectomy	No	312	Yes
6	M	80–85	AGC, RCC	Descending	Yes	No	Nephrectomy Radical total gastrectomy	No	42	No
7	M	55–60	AGC	Splenic flexure	Yes	No	Radical total gastrectomy	No	288	No
8	M	50–55	Pancreas cancer	Splenic flexure	Yes	No		Yes^b	287	Yes
9	F	25–30	AGC	Descending	Yes	No		Yes^c	463	No

F female; M male; PC carcinomatosis peritonei; FUD follow up duration; AGC advanced gastric cancer; MUO Malignancy of undefined primary origin; RCC renal cell carcinoma
^aAge was expressed in a range to maintain anonymity
^bFOLFIRINOX
^cTrastuzumab, capecitabine and cisplatin

ISSN: 1471-230X